Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.64 |
| ▸ | CA1 | P00915 | 4/20 | 0.64 |
| ▸ | CA2 | P00918 | 4/20 | 0.64 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.64 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.64 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.64 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | BLM | P54132 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | FAAH | O00519 | 1/20 | 0.64 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.64 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Thujaplicin SCHEMBL355645 | 0.83 | GABRA1 (0.67) | HPGDCA1CA2GABRA1CYP3A4 | |
| SCHEMBL31658451 | 0.82 | GABRA1 (0.76) | HPGDCA1CA2GABRA1CYP3A4 | |
| SCHEMBL301445 | 0.82 | GABRA1 (0.76) | HPGDCA1CA2GABRA1CYP3A4 | |
| SCHEMBL23250717 | 0.82 | GABRA1 (0.61) | HPGDCA1CA2GABRA1CYP3A4 | |
| SCHEMBL23258468 | 0.80 | GABRA1 (0.59) | HPGDCA1CA2GABRA1CYP3A4 | |
| SCHEMBL23258800 | 0.80 | GABRA1 (0.59) | HPGDCA1CA2GABRA1CYP3A4 | |
| Propofol SCHEMBL36245 | 0.79 | GABRA1 (1.00) | HPGDCA1CA2GABRA1CYP3A4 | |
| Propofol SCHEMBL2414429 | 0.79 | GABRA1 (1.00) | HPGDCA1CA2GABRA1CYP3A4 | |
| SCHEMBL6214964 | 0.77 | GABRA1 (0.55) | HPGDCA1CA2GABRA1CYP3A4 | |
| SCHEMBL6214960 | 0.77 | GABRA1 (0.48) | HPGDCA1CA2GABRA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130209386-A1 | NEW USES | EVOCUTIS PLC (GB) | 2013-08-15 | — | — | US | disclosed |
| EP-2598208-A2 | NEW USES | Evocutis plc (GB) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012172318-A1 | FORMULATIONS CONTAINING TROPOLONOIDS, COPPER SALT AND A SOLVENT SYSTEM | EVOCUTIS PLC (GB) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012013967-A2 | NEW USES | SYNTOPIX GROUP PLC (GB) | 2012-02-02 | — | — | WO | disclosed |
| US-20090283473-A1 | PLANT MATERIALS EXTRACTION METHOD | XYLON BIOTECHNOLOGIES LTD. | 2009-11-19 | — | — | US | disclosed |
| US-20090283473-A1 | PLANT MATERIALS EXTRACTION METHOD | XYLON BIOTECHNOLOGIES LTD. | 2009-11-19 | — | — | US | disclosed |
| US-20070219141-A1 | Plant Materials Extraction Method | JONES DAVID | 2007-09-20 | — | — | US | disclosed |
| US-20070219141-A1 | Plant Materials Extraction Method | JONES DAVID | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219141-A1 | Plant Materials Extraction Method | ALPP, PLK4, PGLS | HPGD 2415/4885CA1 4688/4885CA2 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.